Randomized phase II study of gemcitabine administered at a fixed dose rate or in combination with cisplatin, docetaxel, or irinotecan in patients with metastatic pancreatic cancer: CALGB 89904. (Q37474061)
Jump to navigation
Jump to search
scientific article published on 26 October 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase II study of gemcitabine administered at a fixed dose rate or in combination with cisplatin, docetaxel, or irinotecan in patients with metastatic pancreatic cancer: CALGB 89904. |
scientific article published on 26 October 2009 |
Statements
1 reference
Randomized phase II study of gemcitabine administered at a fixed dose rate or in combination with cisplatin, docetaxel, or irinotecan in patients with metastatic pancreatic cancer: CALGB 89904. (English)
1 reference
Matthew H Kulke
1 reference
Margaret A Tempero
1 reference
Donna Niedzwiecki
1 reference
Donna R Hollis
1 reference
Hedy L Kindler
1 reference
Michael Cusnir
1 reference
Peter C Enzinger
1 reference
Stefan M Gorsch
1 reference
Richard M Goldberg
1 reference
Robert J Mayer
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference